Yposkesi

Yposkesi is a European industrial leader for Gene and Cell Therapy with the mission of developing, manufacturing and making available Gene and Cell therapy treatments to patients affected with rare diseases. It was launched in November 2016 in Corbeil Essonnes (South of Paris, France) by the patient organization AFM-Téléthon with the support of the SPI fund from the French Public Investment Bank (BPI France), with a total investment of €121M. It is made up of 160 experts in bioproduction and has a first production building covering 5,000 m2. The broad expertise of Yposkesi covers the production of viral vectors for gene therapy (Lentivirus & AAV) and the transduction of hematopoietic stem cells, with also significant efforts in developing innovative technologies for large-scale cost-effective manufacturing of these highly complex ATMPs. The plans are to extend the production capacity with two additional buildings for a total of 13’000 m2 by 2021.

show less